×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Skip to main content
Tags: xofluza | flu | drug | 24 | hours | approved | japan

Xofluza, Flu Drug That Kills Virus in 24 Hours, Approved in Japan

Xofluza, Flu Drug That Kills Virus in 24 Hours, Approved in Japan

Emergency department technician Jake Weatherford collects a patient's swab to be tested for the flu at Upson Regional Medical Center in Thomaston, Ga., Friday, Feb. 9, 2018. (AP Photo/David Goldman)

By    |   Friday, 23 February 2018 04:05 PM EST

Xofluza, a new flu drug that has been shown to kill the flu virus in 24 hours with one dose, was approved Friday in Japan after a successful human trial. 

The fast-track approval from Japan’s health ministry allows maker Shionogi & Co. to begin selling the drug in Japan, but it is unlikely to be available before May because no price has yet been set for it by the national insurer, according to The Wall Street Journal.

Unlike existing flu medicines like Tamiflu that try to block viral material from infecting other cells, Xofluza instead stops the virus from hijacking healthy cells to replicate itself, which kills it off sooner. Patients not only seem to recover faster, but are also less likely to pass the virus on to someone else when Xofluza is used, according to maker Shionogi.

The idea for the new flu drug came from HIV drugs currently on the market that work the same way. Nearly 2,500 compounds were tried and rejected before Xofluza was developed, the WSJ reported.

Swiss pharmaceutical company Roche already has the license to sell Xofluza outside Japan, including in the U.S., but U.S. approval is expected to take until 2019.

Tamiflu, the current go-to antiviral drug for flu treatment, takes three days to kill the virus and must be taken twice a day for five days.

This flu season has been the worst since a swine flu pandemic in 2009. The vaccine made for this season has been largely ineffective in treating the prevalent strains this year. 

Other companies such as AstraZeneca PLC and Johnson & Johnson are testing new flu drugs to treat influenza A, which is most common in humans, but are several years away from having drugs ready for market, the WSJ reported. 

© 2022 Newsmax. All rights reserved.


TheWire
Xofluza, a new flu drug that has been shown to kill the flu virus in 24 hours with one dose, was approved Friday in Japan after a successful human trial.
xofluza, flu, drug, 24, hours, approved, japan
295
2018-05-23
Friday, 23 February 2018 04:05 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved
Download the NewsmaxTV App
NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved